Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2008 2
2010 2
2011 2
2012 4
2013 1
2014 5
2015 4
2016 5
2017 2
2018 4
2019 2
2020 5
2021 8
2022 10
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Grymonprez M, Carnoy L, Capiau A, Boussery K, Mehuys E, De Backer TL, Steurbaut S, Lahousse L. Grymonprez M, et al. Among authors: steurbaut s. Eur Heart J Cardiovasc Pharmacother. 2023 Dec 14;9(8):722-730. doi: 10.1093/ehjcvp/pvad070. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37791408
Medication Review: What's in a Name and What Is It about?
Robberechts A, Brumer M, Garcia-Cardenas V, Dupotey NM, Steurbaut S, De Meyer GRY, De Loof H. Robberechts A, et al. Among authors: steurbaut s. Pharmacy (Basel). 2024 Feb 19;12(1):39. doi: 10.3390/pharmacy12010039. Pharmacy (Basel). 2024. PMID: 38392946 Free PMC article. Review.
[Drug related problems in Belgian community pharmacies].
Huysmans K, De Wulf I, Foulon V, De Loof H, Steurbaut S, Boussery K, De Vriese C, Lacour V, Van Hees T, De Meyer GR. Huysmans K, et al. Among authors: steurbaut s. J Pharm Belg. 2014 Mar;(1):4-15. J Pharm Belg. 2014. PMID: 24804389 French.
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.
Grymonprez M, Capiau A, Steurbaut S, Boussery K, Mehuys E, Somers A, Petrovic M, De Backer TL, Lahousse L. Grymonprez M, et al. Among authors: steurbaut s. Cardiovasc Drugs Ther. 2023 Nov 6. doi: 10.1007/s10557-023-07521-5. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37930588
Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis.
Grymonprez M, Vanspranghe K, Capiau A, Boussery K, Steurbaut S, Lahousse L. Grymonprez M, et al. Among authors: steurbaut s. Br J Clin Pharmacol. 2022 Jul;88(7):3039-3051. doi: 10.1111/bcp.15265. Epub 2022 Feb 21. Br J Clin Pharmacol. 2022. PMID: 35132677 Free article. Review.
67 results